The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in real time, with ...
2don MSN
Truveta launches AI research tool to get quick insights from big database of U.S. clinical data
Bellevue, Wash.-based health data company Truveta announced Truveta Intelligence, a new AI-powered tool that lets researchers ...
Morning Overview on MSN
FDA pilots AI and real-time data reviews to speed some clinical trials
A cancer patient enrolled in a clinical trial today might wait months before regulators ever see the safety data generated by ...
The platform is co-led by Dr. Sherry Soltani, Chief Medical Officer, who brings an active clinical perspective to seeCOLe’s ...
Turning fragmented clinical data into actionable insight helps clinicians access unified patient information for faster, informed decisions across ...
PHILADELPHIA, April 28, 2026--iECURE to Present Preliminary Clinical Data from Ongoing OTC-HOPE Trial of ECUR-506 in Neonatal ...
Clinical Trials Arena on MSN
Wave of AI and data science tools set to transform clinical trials
Ahead of Biomed Israel, Ittai Harel highlights a growing cohort of companies leveraging AI and data science tools to ...
TrialClinIQ, an AI-powered clinical trial recruitment platform based in Houston, Texas advancing health equity, today announced a $150K pre-seed investment from Caduceus Capital Partners and its ...
Tailored Approaches in the Treatment of Patients With Colorectal Cancer Harboring Tropomyosin Receptor Kinase Fusion and Microsatellite Instability-High: A Case Report and Literature Review ...
TOS-358 is a covalent, pan-mutant, α-specific PI3K inhibitor designed to address key limitations of existing PI3Kα therapies which include limited mutation coverage and poor tolerability ...
Prospective Study Conducted at Holy Spirit Hospital in Mumbai Reports 95% Vein Occlusion Rate at 30 VANCOUVER, BC, April 30, 2026 (GLOBE NEWSWIRE)-- VVT Med Inc. (TSXV: VVTM) ("VVT Med" or the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results